| 000 | 01658 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515181509.0 | ||
| 264 | 0 | _c20090828 | |
| 008 | 200908s 0 0 eng d | ||
| 022 | _a1874-4745 | ||
| 024 | 7 |
_a10.2174/1874473710801020177 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchaefer, Martin | |
| 245 | 0 | 0 |
_aHepatitis C treatment in patients with drug addiction: clinical management of interferon-alpha-associated psychiatric side effects. _h[electronic resource] |
| 260 |
_bCurrent drug abuse reviews _cJun 2008 |
||
| 300 |
_a177-87 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAlcoholism _xepidemiology |
| 650 | 0 | 4 |
_aAntidepressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntiviral Agents _xadverse effects |
| 650 | 0 | 4 |
_aAnxiety Disorders _xchemically induced |
| 650 | 0 | 4 |
_aDepressive Disorder _xchemically induced |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIllicit Drugs |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xadverse effects |
| 650 | 0 | 4 |
_aMethadone _xtherapeutic use |
| 650 | 0 | 4 |
_aNarcotics _xtherapeutic use |
| 650 | 0 | 4 |
_aPatient Dropouts _xpsychology |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xadverse effects |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 |
_aRibavirin _xadverse effects |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSubstance Abuse, Intravenous _xepidemiology |
| 700 | 1 | _aMauss, Stefan | |
| 773 | 0 |
_tCurrent drug abuse reviews _gvol. 1 _gno. 2 _gp. 177-87 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1874473710801020177 _zAvailable from publisher's website |
| 999 |
_c19039047 _d19039047 |
||